Remove 2023 Remove Health Technology Remove healthcare technology Remove Pain management
article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.

article thumbnail

Digital MSK is starting to fulfil its potential in 2024, IPO's likely in 2025

Lloyd Price

MSK digital health solutions have raised $223M so far this year, already nearly double that of 2023’s $125M. Overall, digital MSK is a promising area in healthcare technology, and 2025 could be a big year for IPOs in this space. Exec Summary: The digital MSK (musculoskeletal) market is on the rise in 2024.